In summary, the findings of this study present fresh insights into class B GPCRs like PTH1R and PTH2R, standing out as sturdy and promising targets for innovative therapeutic in conditions such as migraine and various painful disorders. This evidence concerns the gene PTH1R and migraine disorder.